These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
24. [ACCOMPLISH and the risks with company sponsored clinical trials]. Furberg C Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775 [No Abstract] [Full Text] [Related]
25. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information. Puttagunta PS; Caulfield TA; Griener G Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309 [TBL] [Abstract][Full Text] [Related]
26. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics. Campbell MJ Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038 [No Abstract] [Full Text] [Related]
27. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
28. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. Safer DJ J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091 [TBL] [Abstract][Full Text] [Related]
30. Drug companies cut costs with foreign clinical trials. Rai S N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516 [No Abstract] [Full Text] [Related]
31. Pharmaceutical company-sponsored drug trials: what are we to believe? Shekelle P J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207 [No Abstract] [Full Text] [Related]
32. The pharmaceutical company and the academic medical center: win-win or mutual exploitation? Legato MJ J Gend Specif Med; 2002; 5(1):7-9. PubMed ID: 11859688 [No Abstract] [Full Text] [Related]
33. Getting it right: industry sponsorship and medical research. Baird P CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071 [No Abstract] [Full Text] [Related]
34. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
35. The negotiation and development of a clinical trial agreement. Finn PB J Biolaw Bus; 2006; 9(2):21-7. PubMed ID: 17111523 [TBL] [Abstract][Full Text] [Related]
36. Coercion in the recruitment and retention of human research subjects, pharmaceutical industry payments to physician-investigators, and the moral courage of the IRB. DeRenzo EG IRB; 2000; 22(2):1-5. PubMed ID: 11883465 [No Abstract] [Full Text] [Related]
37. Pharma buys a conscience. Elliott C Am Prospect; 2001 Sep 24-Oct 8; 12(17):16-20. PubMed ID: 16184653 [No Abstract] [Full Text] [Related]
38. Researchers facing increasing costs for clinical research, with few solutions. Erdmann J J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558 [No Abstract] [Full Text] [Related]
39. Clinical trials in India: balancing economic opportunity with the public health context. Dandona L Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189 [No Abstract] [Full Text] [Related]